Enliven Therapeutics Inc. (ELVN)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

0 $0 0%
2.
OrbiMed Advisors

Samuel Isaly

0 $0 0%
3.
RA Capital Management

Peter Kolchinsky

0 $0 0%
4.
Commodore Capital

Egen Atkinson And Michael Kramarz

0 $0 0%
5. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
Large Shareholder
$22.07 622 $13,723.27 718,749 2023-02-23 Filing
Large Shareholder
$5.11 23,565 $120,487.85 2,872,513 2023-02-22 Filing
Large Shareholder
$5.25 8,194 $43,010.31 2,848,948 2023-02-21 Filing
Large Shareholder
$4.00 629,297 $2,516,055.27 3,880,021 2023-01-03 Filing
Large Shareholder
$3.93 19,299 $75,845.07 3,250,724 2022-12-09 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
 
$22.55 3,000 $67,655.40 23,000 2025-06-13 Filing
 
$21.16 60 $1,269.60 303,309 2025-06-09 Filing
 
$20.33 6,607 $134,304.45 303,369 2025-06-09 Filing
 
$20.03 7,500 $150,219.75 977,688 2025-06-03 Filing
 
$20.05 7,500 $150,351.75 965,392 2025-06-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 0 $0 0%
2. 0 $0 0%
3. 0 $0 0%
News See All